Christian Jones

Christian Jones

BakerHostetler

Contact

Readers' Choice Awards

Healthcare
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Capitol Hill Healthcare Update

HEALTH PROVISIONS FACE UNCERTAINTY AS CONGRESS RETURNS FOR BUSY DECEMBER - Lawmakers return to Washington this week after the Thanksgiving holiday with only 18 days before the government runs out of money – and that’s not...more

12/2/2019  /  Drug Pricing , Food and Drug Administration (FDA) , PCORI , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

FDA NOMINATION HEARING DRIVES THE WEEK IN HEALTH POLICY - President Trump’s nominee to lead the Food and Drug Administration, Dr. Stephen Hahn, will appear Wednesday before the Senate Health, Education, Labor and Pensions...more

11/19/2019  /  Data Collection , Food and Drug Administration (FDA) , Google , Pharmaceutical Industry , Pharmaceutical Patents , Trump Administration

Capitol Hill Healthcare Update

COMPREHENSIVE DRUG BILL STALLS WHILE HOUSE PUSHES SMALLER MEASURES - House Democrats are planning to take up more narrow bills addressing prescription drug costs while their broad legislation is delayed as the...more

11/13/2019  /  Congressional Budget Office , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

PELOSI INTRODUCES DRUG PRICING BILL WHILE TRUMP PUSHES SENATE VERSION - House Democrats introduced legislation last week to lower prescription drug prices – including allowing Medicare to negotiate prices with...more

9/23/2019  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more

6/11/2019  /  Data Breach , Data Protection , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare for All , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Prior Authorization

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Note that because Congress will be in recess for the Memorial Day holiday, the next “Capitol Hill Healthcare...more

5/21/2019  /  Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Durable Medical Equipment , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. DRUG PRICES: CONGRESS RETURNS, PICKS UP WHERE LAWMAKERS LEFT OFF - Congress reconvenes today after a...more

4/29/2019  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare for All , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. GOTTLIEB, HARGAN TO TESTIFY ON 2020 HEALTH BUDGET, PROGRAMS - Outgoing FDA Commissioner Scott Gottlieb and...more

3/25/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare , Medicare for All , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Azar testifies before three committees on HHS’ budget; a series of Senate bills targeting...more

3/11/2019  /  Biologics , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices;...more

3/4/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Pharma industry CEOs testify before a Senate committee; House and Senate panels probe...more

2/26/2019  /  Centers for Medicare & Medicaid Services (CMS) , Cybersecurity , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: shutdown risk increases as talks stall; Gottlieb’s Hill testimony postponed; more bills...more

2/12/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicaid , Medicare Part D , Opioid , Pharmaceutical Industry , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address;...more

2/5/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Preexisting Conditions , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug...more

1/29/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves Medicaid measures, and more....more

1/23/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicaid , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Trump Administration

Capitol Hill Healthcare Update

Highlights this week: Nearly 7,000 FDA employees are furloughed amid the ongoing government shutdown; lawmakers introduce a slew of anti-pharma bills; 18 new Democrats land plum spots on key healthcare committees; and more....more

1/14/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Tax Deductions

Capitol Hill Healthcare Update

Highlights this week: how the partial government shutdown is affecting operations at the FDA; House Democrats take steps to defend the ACA; the House votes this week to renew emergency health response programs; new senators...more

1/8/2019  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Highlights this week include a lame duck update on year-end health bills and tax provisions; lawmakers reacting to a federal judge ruling the Affordable Care Act is unconstitutional; Sen. Hatch seeks to update Hatch-Waxman;...more

12/17/2018  /  Affordable Care Act , Congressional Budget Office , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Furloughs , Government Shutdown , Medicare Part D , Patents , Pharmaceutical Industry , Trump Administration , USPTO

Capitol Hill Healthcare Update

Highlights this week: Lawmakers renew efforts to avoid a partial government shutdown, which would affect FDA; key senators introduce legislation on Medicaid prescription drug rebates; the House votes this week on allowing...more

12/10/2018  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicare , Prescription Drugs , Rebates , Trump Administration

Capitol Hill Healthcare Update

Highlights this week: Healthcare legislative priorities are caught up in a separate spending debate that could lead to a partial government shutdown; some GOP lawmakers push back on Trump’s Part B pilot program; a key...more

12/4/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Highlights this week: Democrats’ takeover of the House will yield big changes for healthcare policy in 2019; several GOP lawmakers active in healthcare policy are defeated; pharma pushes for Part D changes in the lame duck;...more

11/13/2018  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Lame Duck Session , Medical Devices , Medicare , Medicare Part A , Medicare Part D , Pharmaceutical Industry , Prescription Drug Coverage

Five Things to Know: What The Election Results Mean for Healthcare Policy

Democrats’ slender majority in the House next year will have an outsized impact on healthcare policy and healthcare stakeholders in 2019 and beyond. From potential bipartisan deals on prescription drug prices to Democrats’...more

11/9/2018  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Opioid , Trump Administration

Capitol Hill Healthcare Update

Included this week is an update on congressional efforts to finish opioids response legislation; efforts by pharmaceutical manufacturers to change discounts they are required to provide Medicare beneficiaries in the Part D...more

9/25/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

This week’s “Capitol Hill Healthcare Update” includes the latest on a pending Senate vote on opioid legislation as Congress races to enact a response to the crisis before the November election; the Senate votes to expand...more

9/11/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Disclosure Requirements , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

This week’s “Capitol Hill Healthcare Update” includes the latest on Congress reconvening after a summer break and facing near-term deadlines on government funding, including for healthcare agencies and programs; whether...more

9/5/2018  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Opioid , Pharmaceutical Industry , Pharmacies , Popular , Prescription Drugs , Section 340B , Trump Administration
75 Results
 / 
View per page
Page: of 3
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide